Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients.

Moskovitz DN, Bodian C, Chapman ML, Marion JF, Rubin PH, Scherl E, Present DH.

Am J Gastroenterol. 2004 Apr;99(4):656-61.

PMID:
15089898
2.

Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan.

Naganuma M, Kunisaki R, Yoshimura N, Nagahori M, Yamamoto H, Kimura H, Sako M, Kawaguchi T, Takazoe M, Yamamoto S, Matsui T, Hibi T, Watanabe M.

J Crohns Colitis. 2011 Aug;5(4):317-23. doi: 10.1016/j.crohns.2011.02.003. Epub 2011 Mar 11.

PMID:
21683301
3.

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.

Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.

Dig Liver Dis. 2005 Jun;37(6):407-17. Review.

PMID:
15893279
4.

Complications of pregnancy and child development after cessation of treatment with 6-mercaptopurine for inflammatory bowel disease.

Zlatanic J, Korelitz BI, Rajapakse R, Kim PS, Rubin SD, Baiocco PJ, Panagopoulos G.

J Clin Gastroenterol. 2003 Apr;36(4):303-9.

PMID:
12642735
5.

Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis.

Rahimi R, Nikfar S, Rezaie A, Abdollahi M.

Reprod Toxicol. 2008 Feb;25(2):271-5. doi: 10.1016/j.reprotox.2007.11.010. Epub 2007 Dec 4.

PMID:
18242053
6.

Fertility and pregnancy in inflammatory bowel disease.

Weterman IT.

Neth J Med. 1989 Jun;35 Suppl 1:S67-75.

PMID:
2702315
7.

Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.

Reddy D, Murphy SJ, Kane SV, Present DH, Kornbluth AA.

Am J Gastroenterol. 2008 May;103(5):1203-9. doi: 10.1111/j.1572-0241.2007.01756.x. Epub 2008 Apr 16.

PMID:
18422816
8.

Inflammatory bowel disease: management issues during pregnancy.

Ferrero S, Ragni N.

Arch Gynecol Obstet. 2004 Sep;270(2):79-85. Epub 2003 Apr 30. Review.

PMID:
12721680
9.

The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.

Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH.

Gastroenterology. 2003 Jan;124(1):9-17.

PMID:
12512024
10.

5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.

Hande S, Wilson-Rich N, Bousvaros A, Zholudev A, Maurer R, Banks P, Makrauer F, Reddy S, Burakoff R, Friedman S.

Inflamm Bowel Dis. 2006 Apr;12(4):251-7.

PMID:
16633046
11.

Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.

Coelho J, Beaugerie L, Colombel JF, Hébuterne X, Lerebours E, Lémann M, Baumer P, Cosnes J, Bourreille A, Gendre JP, Seksik P, Blain A, Metman EH, Nisard A, Cadiot G, Veyrac M, Coffin B, Dray X, Carrat F, Marteau P; CESAME Pregnancy Study Group (France).

Gut. 2011 Feb;60(2):198-203. doi: 10.1136/gut.2010.222893. Epub 2010 Nov 29.

PMID:
21115547
12.

Is safety infliximb during pregnancy in patients with inflammatory bowel disease?

Argüelles-Arias F, Castro-Laria L, Barreiro-de Acosta M, García-Sánchez MV, Guerrero-Jiménez P, Gómez-García MR, Cordero-Ruiz P, Iglesias-Flores E, Gómez-Camacho F, Domínguez-Muñoz EJ, Herrerías-Gutiérrez JM.

Rev Esp Enferm Dig. 2012 Feb;104(2):59-64.

13.

The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD).

Shim L, Eslick GD, Simring AA, Murray H, Weltman MD.

J Crohns Colitis. 2011 Jun;5(3):234-8. doi: 10.1016/j.crohns.2011.01.009. Epub 2011 Feb 22.

PMID:
21575887
14.

Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease.

Riis L, Vind I, Politi P, Wolters F, Vermeire S, Tsianos E, Freitas J, Mouzas I, Ruiz Ochoa V, O'Morain C, Odes S, Binder V, Moum B, Stockbrügger R, Langholz E, Munkholm P; European Collaborative study group on Inflammatory Bowel Disease.

Am J Gastroenterol. 2006 Jul;101(7):1539-45.

PMID:
16863558
15.

Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.

Ban L, Tata LJ, Fiaschi L, Card T.

Gastroenterology. 2014 Jan;146(1):76-84. doi: 10.1053/j.gastro.2013.09.061. Epub 2013 Oct 12.

PMID:
24126096
16.

Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.

Mogadam M, Dobbins WO 3rd, Korelitz BI, Ahmed SW.

Gastroenterology. 1981 Jan;80(1):72-6.

PMID:
6108894
17.

Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines.

Teruel C, López-San Román A, Bermejo F, Taxonera C, Pérez-Calle JL, Gisbert JP, Martín-Arranz M, Ponferrada A, Van Domselaar M, Algaba A, Estellés J, López-Serrano P, Linares PM, Muriel A.

Am J Gastroenterol. 2010 Sep;105(9):2003-8. doi: 10.1038/ajg.2010.138. Epub 2010 Aug 10.

PMID:
20700117
18.

Management of inflammatory bowel disease during pregnancy and nursing.

Friedman S.

Semin Gastrointest Dis. 2001 Oct;12(4):245-52.

PMID:
11726078
19.

Inflammatory Bowel Disease During Pregnancy.

Rajapakse R, Korelitz BI.

Curr Treat Options Gastroenterol. 2001 Jun;4(3):245-251.

PMID:
11469981
20.

The use of medications for inflammatory bowel disease during pregnancy and nursing.

Sauk J, Kane S.

Expert Opin Pharmacother. 2005 Sep;6(11):1833-9. Review.

PMID:
16144504
Items per page

Supplemental Content

Write to the Help Desk